Horizon Pharma PLC (NASDAQ:HZNP) investors scurried sending shares crashing 35% yesterday once the biotech firm released disappointing first quarter earnings for the year …
Horizon Pharma PLC (NASDAQ:HZNP) announced that it has received a Notice of Allowance from the United States Patent and Trademark Office for U.S.
Horizon Pharma PLC (NASDAQ:HZNP) and its affiliate Horizon Therapeutics Canada Limited announced that QUINSAIR (levofloxacin inhalation solution) is now available in Canada for the management …
Horizon Pharma PLC (NASDAQ:HZNP) shares are ascending 7% currently in pre-market trading following the news that Express Scripts has made its formulary decision …
Horizon Pharma PLC (NASDAQ:HZNP) has had a recent misstep on its hands with a Phase 3 flop in its Actimmune Friedrich’s Ataxia (FA) …
Ahead of the Express Scripts formulary decision, the next significant catalyst for Horizon Pharma PLC (NASDAQ:HZNP), Mizuho analyst Irina Rivkind Koffler makes a …
Shares of Horizon Pharma PLC (NASDAQ:HZNP) and Radius Health Inc (NASDAQ:RDUS) each plunged more than 10% Thursday following disappointing clinical trial results. Let’s …
Horizon Pharma PLC (NASDAQ:HZNP) shareholders are having a rough morning after the drug maker announced that its Phase III STEADFAST trial of Actimmune in …
Horizon Pharma PLC (NASDAQ:HZNP) announced that a retrospective analysis of data from previous pivotal, randomized KRYSTEXXA® (pegloticase) clinical trials demonstrate that refractory chronic …
Horizon Pharma PLC (NASDAQ:HZNP) announced its third-quarter 2016 financial results today and confirmed its full-year 2016 GAAP net sales, non-GAAP adjusted net sales …
